Center for Neurobiology and Behavior, Columbia University, 630 West 168th Street, P&S 12-510, New York, NY 10032, USA.
Alzheimers Res Ther. 2010 Dec 15;2(6):33. doi: 10.1186/alzrt57.
While Alzheimer's disease researchers continue to debate the underlying cause(s) of the disease, most agree that a diverse, multi-target approach to treatment will be necessary. To this end, the Alzheimer's Drug Discovery Foundation (ADDF) recently hosted the 11th International Conference on Alzheimer's Drug Discovery to highlight the array of exciting efforts from the ADDF's funded investigators.
虽然阿尔茨海默病研究人员仍在争论该疾病的根本原因，但大多数人都同意，需要采取多样化的多靶点治疗方法。为此，阿尔茨海默病药物发现基金会（ADDF）最近举办了第 11 届阿尔茨海默病药物发现国际会议，重点介绍 ADDF 资助的研究人员所开展的一系列令人兴奋的工作。
